Skip to main content
Equibles
ARCT logo

ARCT · Arcturus Therapeutics Holdings Inc.

Track ARCT — free

Use ARCT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ARCT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.23 +0.37 (+4.71%) At close · Aug 14
Market Cap
$233.92M
Shares
28.42M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-06 Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress READ MORE Event
2026-07-28 Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 READ MORE Event
2026-07-20 Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference READ MORE Conference
2026-07-02 Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis READ MORE Event
2026-05-26 Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference READ MORE Conference
2026-05-07 Earnings conference call (announced in 8-K) Earnings call
2026-04-27 Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 READ MORE Event
2026-03-05 Arcturus Therapeutics to Attend Upcoming Investor Conference READ MORE Conference
2026-03-03 Earnings conference call (announced in 8-K) Earnings call
2026-02-17 Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 READ MORE Event
2026-01-08 Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference READ MORE Conference
2025-11-24 Arcturus Therapeutics to Attend Upcoming Investor Conference READ MORE Conference
2025-11-10 Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress READ MORE Event
2025-11-04 Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE Conference
2025-10-28 Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025 READ MORE Event
2025-10-22 Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program READ MORE Event
2025-08-26 Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE Conference
2025-08-11 Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress READ MORE Event
2025-07-24 Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 READ MORE Event
2025-07-23 Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE Conference
2025-06-30 Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program READ MORE Event
2025-06-23 Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency READ MORE Presentation
2025-05-29 Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE Conference
2025-05-12 Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress READ MORE Event

Source: https://ir.arcturusrx.com/

Key facts CIK 1768224 CUSIP 03969T109 13F (30d) 129 filings 128 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)